We have heard your request – New Pick Coming! Dear Fellow Traders, We believe that we have some more exciting trading opportunities lined up. We are compiling our data as we speak so stay tuned! I am researching a few different companies and will be announcing your next New Blockbuster Pick Alert shortly.

For Now I Want You To Be on High Alert and Ready to Act! Sincerely, The OTCtipReporter Team GENERAL NOTICE AND DISCLAIMER – PLEASE READ CAREFULLY The companies that are discussed on OTCtipReporter.com have not approved the statements made. This opinion contains forward-looking statements that involve risks and uncertainties. A company`s actual results could differ materially from those described in any forward-looking statements or announcements discussed herein. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCtipReporter.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Nor are any of its officers, affiliates, or employees. Please consult a broker before purchasing or selling any securities viewed on OTCtipReporter.com or mentioned herein.

Affiliates, officers, directors and employees of OTCtipReporter.com may have also bought or may buy shares of companies mentioned herein and may profit in the event those shares rise in value.

OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make their own decision based on his or her judgment of the market. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. We recommend you use the information found in this advertisement as an initial starting point for conducting your own research on the advertised company in order to determine your own personal opinion of the company before investing. All statements and opinions contained in this advertisement are the sole opinion of the authors and are subject to change without notice. We are not liable for any investment decisions by our readers. Readers should independently investigate and fully understand all risks before investing. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser or broker prior to completing any such purchase or sale decision. We are not registered investment advisers, or broker-dealers, or members of any financial regulatory bodies. Furthermore, our associates and/or employees and/or principals may have stock positions in advertised companies purchased in the open market or in private transactions. These positions may be liquidated, without prior notification, even after we have made positive comments regarding the advertised company. The receipt of this information constitutes your acceptance of these terms and conditions. Reading this advertisement shall not create under any circumstances an offer to buy or sell stock in any company advertised. Nor shall it create any principal-agent relationship between the reader and us. Void where prohibited. Information within this advertisement contains “forward looking” statements within the meaning of Section-27(a) of the U.S.

Securities Act-of-1933 and Section 21(e) of the U.S. Securities Exchange Act-of -934. Neither OTCtipReporter.com, its officers, affiliates, or employees is a broker-dealer. The information on OTCtipReporter.com, including the opinions expressed and the statements made within, is for informational and advertising purposes only and should not be construed as investment-advice, and does not constitute an offer to sell any securities, nor is it to be construed as a solicitation to purchase any securities in any state or other jurisdiction where the offer or sale is not permitted. The information to prepare this report is believed to be from reliable sources, but no representation is made as to the accuracy or completeness of such information. Investment in securities carries a high degree of risk and involves risks and uncertainties, which may result in investors losing all of their invested capital. Past performance does not guarantee future results.The information contained herein contains “forward-looking statements,” within the meaning of Section-27A of the Securities Act-of-1933 and Section 21E of the Securities Exchange Act-of-1934.

Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense competition, lack of meaningful research results, inadequate capital, termination of contracts or agreements, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in the reports filed with the Securities and Exchange Commission by the companies who are mentioned in this periodical. Readers should consult with their own professional investment, tax and portfolio advisors before making any investment decision and should independently verify all information herein.

More complete information about any of the companies mentioned in this periodical is available from the website of the Securities and Exchange Commission, at sec.gov, and copies of their filings may be read without charge and copies obtained at prescribed rates from the public reference facilities of the Commission, at 450 Fifth Street, NW, Washington, DC 20549.

Buying and Selling of Shares OTCtipReporter.com intends to sell its shares. OTCtipReporter.com may sell its shares for less than target prices given in opinions.

OTCtipReporter.com affiliates, officers, directors and employees may have also bought or may buy the shares discussed in this report and may profit in the event those shares rise in value.

OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. There are risks involved Always remember that OTCtipReporter.com are not analysts and investing in securities such as the ones listed within are for high risk tolerant individuals only and not the general public. Whether you are an experienced investor or not you should always consult with a broker before purchasing or selling any securities viewed on OTCtipReporter.com. If at any time you wish to be removed from our list simply

No tags

(Breaking News!) just hit the wire at 10:23 AM Today Microelectronics Technology Co. (MELY) MELY just announced that the company is in final contract negotiations with a third party vendor for the establishment of a “White Label” relationship for the companies proprietary DomainStutter technology. (Read Full Press Release Below) PRESS RELEASE:

Cloud Data Corp to Expand its DomainStutter Technology Establishing New Brand through White Label Contract May 2, 2012 10:23:00 AM MONARCH BAY, Calif., May 2, 2012 /PRNewswire/ — Cloud Data Corp a fully owned subsidiary ofMicroelectronics Technology Corporation (OTC-BB: MELY.PK) is pleased to announce that the company is in final contract negotiations with a third party vendor for the establishment of a “White Label” relationship for the companies proprietary DomainStutter technology.

The DomainStutter technology offers clients rapid domain deployment with each domain having unique content automatically inserted into the site. The system harnesses the power of cloud computing to enable clients the ability to deploy thousands of sites with minimal time and effort. Clients can deploy thousands of domain host sites on an accelerated basis, with unique content, with virtually no effort due to use of the proprietary DomainStutter technology.

The practice of multiple domain name deployment is commonly known as domain parking and may also refer to an advertising practice known as parked domain monetization used primarily by domain name registrars and Internet advertising publishers to monetize Internet traffic visiting a parked or minimally developed domain name property.

The domain name will usually lead to a web page containing advertising listings and links. These links will be targeted to the predicted interests of the visitor and may change dynamically based on the results that visitors click on. Usually the domain holder is paid based on how many links have been visited (e.g.pay per click or page view) and on how beneficial those visits have been. The keywords for any given domain name provide the type of profile that will determine the intent of the Internet traffic before arriving.

DomainStutters capability to deliver unique content to each individual domain automatically, allows the parked domain to better differentiate itself to search engines allowing for higher indexing and ratings resulting in higher traffic generation, which in turn leads to higher per domain revenue generation.

“These negotiations have been finalized subject to formal documentation,” stated Microelectronic Technology company president Brett Everett. ” The company looks forward to the introduction of a new `White Label` partner for the roll out of a unique brand of business for the DomainStutter Technology providing for another revenue stream to Cloud Data Corp from the exploitation of its existing suite of technologies and services.” Contract finalization is expected by May 31, 2012.

The company continues to progress on its roll out of the Dynamo server offering which will consist of valued priced dedicated server rentals to third party customers. The servers will be located within Canada. This division is a response to the significant demand by the company`s customer base, creating a niche market for the company to exploit with the assurance of an in place customer base upon initiation.

The company is currently completing its co-location selection and sign off, and hardware acquisition.

The company expects to roll out its offering in May 2012.

Initiating the company`s entry into this multi billion dollar marketplace in conjunction with the development of the www.Sproq.com For further Information:

Microelectronics Technology Co.

President:

Mr. Brett Everett 1 866 587 2860 www.melypk.com www.clouddatacorp.com www.sproq.com www.domainstutter.com Forward-Looking Statements This news release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey Company progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management`s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the Company at this time, actual results may differ materially and are subject to risk and uncertainties.

Factors that may cause actual results to differ include without limitation: dependence on key personnel and suppliers; MELY`s ability to commercialize its technology; ability to defend intellectual property; material and component costs; competition; economic conditions; consumer demand and product acceptance, and availability of growth capital.

Additional considerations and risk factors are set forth in reports filed on Form 8-K and 10-K with the SECand other filings. Readers are cautioned not to place undue reliance upon these forward-looking statements; historical information is not an indicator of future performance. The Company undertakes no obligation to update publicly any forward-looking statements.

We believe that we have some more exciting trading opportunities for this week. We are compiling our data as we speak so stay tuned! I am researching a few different companies and will be announcing your next New Blockbuster Pick Alert shortly.

….Be on High Alert and Ready to Act! We Have an Amazing Week Ahead! Sincerely, The OTCtipReporter Team GENERAL NOTICE AND DISCLAIMER – PLEASE READ CAREFULLY The companies that are discussed on OTCtipReporter.com have not approved the statements made. This opinion contains forward-looking statements that involve risks and uncertainties. A company`s actual results could differ materially from those described in any forward-looking statements or announcements discussed herein. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCtipReporter.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Nor are any of its officers, affiliates, or employees. Please consult a broker before purchasing or selling any securities viewed on OTCtipReporter.com or mentioned herein.

Affiliates, officers, directors and employees of OTCtipReporter.com may have also bought or may buy shares of companies mentioned herein and may profit in the event those shares rise in value.

OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make their own decision based on his or her judgment of the market. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. We recommend you use the information found in this advertisement as an initial starting point for conducting your own research on the advertised company in order to determine your own personal opinion of the company before investing. All statements and opinions contained in this advertisement are the sole opinion of the authors and are subject to change without notice. We are not liable for any investment decisions by our readers. Readers should independently investigate and fully understand all risks before investing. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser or broker prior to completing any such purchase or sale decision. We are not registered investment advisers, or broker-dealers, or members of any financial regulatory bodies. Furthermore, our associates and/or employees and/or principals may have stock positions in advertised companies purchased in the open market or in private transactions. These positions may be liquidated, without prior notification, even after we have made positive comments regarding the advertised company. The receipt of this information constitutes your acceptance of these terms and conditions. Reading this advertisement shall not create under any circumstances an offer to buy or sell stock in any company advertised. Nor shall it create any principal-agent relationship between the reader and us. Void where prohibited. Information within this advertisement contains “forward looking” statements within the meaning of Section-27(a) of the U.S.

Securities Act-of-1933 and Section 21(e) of the U.S. Securities Exchange Act-of -934. Neither OTCtipReporter.com, its officers, affiliates, or employees is a broker-dealer. The information on OTCtipReporter.com, including the opinions expressed and the statements made within, is for informational and advertising purposes only and should not be construed as investment-advice, and does not constitute an offer to sell any securities, nor is it to be construed as a solicitation to purchase any securities in any state or other jurisdiction where the offer or sale is not permitted. The information to prepare this report is believed to be from reliable sources, but no representation is made as to the accuracy or completeness of such information. Investment in securities carries a high degree of risk and involves risks and uncertainties, which may result in investors losing all of their invested capital. Past performance does not guarantee future results.The information contained herein contains “forward-looking statements,” within the meaning of Section-27A of the Securities Act-of-1933 and Section 21E of the Securities Exchange Act-of-1934.

Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense competition, lack of meaningful research results, inadequate capital, termination of contracts or agreements, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in the reports filed with the Securities and Exchange Commission by the companies who are mentioned in this periodical. Readers should consult with their own professional investment, tax and portfolio advisors before making any investment decision and should independently verify all information herein.

More complete information about any of the companies mentioned in this periodical is available from the website of the Securities and Exchange Commission, at sec.gov, and copies of their filings may be read without charge and copies obtained at prescribed rates from the public reference facilities of the Commission, at 450 Fifth Street, NW, Washington, DC 20549.

Buying and Selling of Shares OTCtipReporter.com intends to sell its shares. OTCtipReporter.com may sell its shares for less than target prices given in opinions.

OTCtipReporter.com affiliates, officers, directors and employees may have also bought or may buy the shares discussed in this report and may profit in the event those shares rise in value.

OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. There are risks involved Always remember that OTCtipReporter.com are not analysts and investing in securities such as the ones listed within are for high risk tolerant individuals only and not the general public. Whether you are an experienced investor or not you should always consult with a broker before purchasing or selling any securities viewed on OTCtipReporter.com. If at any time you wish to be removed from our list simply

MELY · PRESS

SGAE Shocking Monster GOLD Pick Alert! Dear Fellow Traders, My Shocking New Monster Gold Pick is:

Siga Resources Inc. (SGAE) SGAE is a gold and mineral exploration company with a public float of just over 20 million shares and a current low entry point. With a low float and attractive entry price, SGAE has the potential to see significant gains in a very short amount of time as it gains momentum and trading activity increases. With all the right characteristics, investors seeking to leverage current trends could kick start a major increase in volume for SGAE, which could be just the catalyst it needs to go break through resistance levels and sky rocket back up towards its 52 week highs of $2.50 per share! SGAE is small because of its relatively low market valuation and has large potential because they could be pulling around a billion dollars worth of gold out of their mines in the future if the geologists are right! I highly suggest you begin your research immediately on SGAE: a company primed to see enormous gains on a very quick turnaround! About Siga Resources (SGAE) Siga Resources Inc. is a gold and mineral exploration company incorporated in Nevada in 2007. Siga is currently based in South Lake Tahoe, California. Under new management since September 2010, Siga has a revised corporate strategy and is targeting precious metals properties that have the potential for production and early positive cash flow.

Investment Highlights SGAE has acquired 100% of the Lucky Thirteen Mining property in British Columbia. In a 2007 report by by T. Sadlier Brown and P.

Geo reported that the more recently documented sampling programs in the tested area of the gravel bar estimated approximately 250,000 oz of gold contained in approx 4 million cubic yards of sands and gravels.

Also in the Report, an undetermined but possibly significant amount of platinum group metals (PGEs) Survey indicates the initial area of interest contains 12 million cubic yards (21 million short tons) of sand and gravels to a depth of 20 meters above sea level; given reports, potential seems excellent.

SGAE controls a 100% interest in the Valolo Gold Claim located in the Republic of Fiji. Valolo is the project that Siga was founded to explore. The current corporate focus is toward more advanced or near production projects than the Valolo, therefore, is a second priority to other projects.

SGAE is a small Gold stock with Huge Growth potential! SGAE is small because of its relatively low market valuation and has Huge Growth Potential because they could be pulling around a billion dollar`s worth of Gold out of their mines in the future if the geologists are right! Technical Indicators:

SGAE has a very positive outlook on future production. The company primarily holds a 100% interest in the Valolo Gold Claim covering an area of approximately 72.5 hectares located in the Republic of Fiji as well as newly negotiated agreement for the purchase of American Hill Aggregates LTD interest in Lot 57, which underlies a portion of its Lucky Thirteen Placer Claim. Siga expects to close the purchase no later than the end of April 2012.

On a regional basis the area of Fiji in which the Valolo Claim is located is notable for epithermal gold mineralization such as that exploited at the Nasoata Mine. Structures and shear zones affiliated with mineralization on adjacent properties pass through the Valolo Claim. While Data is still being compiled for the Lucky Thirteen project, an empirically derived estimate of the average Gold Value encountered by reports according to the SGAE website, is on the order of $42 per cubic yard at 2007 gold prices of $675 per ounce, which translates to roughly $105 per cubic yard at current prices of $1700 per ounce.

In addition, SGAE low float allows for significant movement within a short time frame even without significant institutional support. With a market Capitalization of $7Million and around 45,000,000 shares outstanding, SGAE`s public float is just above 20 million shares.

With several of the major qualities that investors may seek out in order to see near term gains, an increase in trading activity could take SGAE on a breakout run. With its current low entry point, and 52 week high of $2.50 per share, SGAE has plenty of room to grow!! SGAE has Enormous Growth Potential. Given the recent news and compelling technical charts that show positive trends for Gold markets as a whole, a momentum gain for SGAE looks very possible and could quickly reach the threshold needed to skyrocket SGAE to its levels up near its historic highs.

Put SGAE on your watch list immediately! They Recently Completed A Purchase Agreement With American Hill Aggregates On Lucky Thirteen Placer! With two major projects; the Lucky Thirteen Placer and the Valolo Gold Exploration Claim, SGAE could see Major Growth from successful production.

With positive outlooks for production, and current market conditions that could prompt investors to look for more opportunities in the Gold stocks, SGAE`s low float, attractive entry point, and high return potential could send SGAE on a run back up towards its 52 week highs! I recommend starting your own research on SGAE this evening. This could be a Huge Stock Play. So move quickly to enjoy the rewards! Now let`s grab some serious gains! Make sure SGAE is on you RADAR for Monday`s trading session! As always we encourage subscribers to do their own due diligence and visit the company website: www.sigaresourcesinc.com HAPPY TRADING! The OTCtipReporter Team GENERAL NOTICE AND DISCLAIMER – PLEASE READ CAREFULLY The companies that are discussed on OTCtipReporter.com have not approved the statements made. This opinion contains forward-looking statements that involve risks and uncertainties. A company`s actual results could differ materially from those described in any forward-looking statements or announcements discussed herein. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCtipReporter.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Nor are any of its officers, affiliates, or employees. Please consult a broker before purchasing or selling any securities viewed on OTCtipReporter.com or mentioned herein.

Affiliates, officers, directors and employees of OTCtipReporter.com may have also bought or may buy shares of companies mentioned herein and may profit in the event those shares rise in value.

OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make their own decision based on his or her judgment of the market. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. We recommend you use the information found in this advertisement as an initial starting point for conducting your own research on the advertised company in order to determine your own personal opinion of the company before investing. All statements and opinions contained in this advertisement are the sole opinion of the authors and are subject to change without notice. We are not liable for any investment decisions by our readers. Readers should independently investigate and fully understand all risks before investing. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser or broker prior to completing any such purchase or sale decision. We are not registered investment advisers, or broker-dealers, or members of any financial regulatory bodies. Furthermore, our associates and/or employees and/or principals may have stock positions in advertised companies purchased in the open market or in private transactions. These positions may be liquidated, without prior notification, even after we have made positive comments regarding the advertised company. The receipt of this information constitutes your acceptance of these terms and conditions. Reading this advertisement shall not create under any circumstances an offer to buy or sell stock in any company advertised. Nor shall it create any principal-agent relationship between the reader and us. Void where prohibited. Information within this advertisement contains “forward looking” statements within the meaning of Section-27(a) of the U.S.

Securities Act-of-1933 and Section 21(e) of the U.S. Securities Exchange Act-of -934. Neither OTCtipReporter.com, its officers, affiliates, or employees is a broker-dealer. The information on OTCtipReporter.com, including the opinions expressed and the statements made within, is for informational and advertising purposes only and should not be construed as investment-advice, and does not constitute an offer to sell any securities, nor is it to be construed as a solicitation to purchase any securities in any state or other jurisdiction where the offer or sale is not permitted. The information to prepare this report is believed to be from reliable sources, but no representation is made as to the accuracy or completeness of such information. Investment in securities carries a high degree of risk and involves risks and uncertainties, which may result in investors losing all of their invested capital. Past performance does not guarantee future results.The information contained herein contains “forward-looking statements,” within the meaning of Section-27A of the Securities Act-of-1933 and Section 21E of the Securities Exchange Act-of-1934.

Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense competition, lack of meaningful research results, inadequate capital, termination of contracts or agreements, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in the reports filed with the Securities and Exchange Commission by the companies who are mentioned in this periodical. Readers should consult with their own professional investment, tax and portfolio advisors before making any investment decision and should independently verify all information herein.

More complete information about any of the companies mentioned in this periodical is available from the website of the Securities and Exchange Commission, at sec.gov, and copies of their filings may be read without charge and copies obtained at prescribed rates from the public reference facilities of the Commission, at 450 Fifth Street, NW, Washington, DC 20549.

Buying and Selling of Shares OTCtipReporter.com intends to sell its shares. OTCtipReporter.com may sell its shares for less than target prices given in opinions.

OTCtipReporter.com affiliates, officers, directors and employees may have also bought or may buy the shares discussed in this report and may profit in the event those shares rise in value.

OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. There are risks involved Always remember that OTCtipReporter.com are not analysts and investing in securities such as the ones listed within are for high risk tolerant individuals only and not the general public. Whether you are an experienced investor or not you should always consult with a broker before purchasing or selling any securities viewed on OTCtipReporter.com. If at any time you wish to be removed from our list simply

SGAE

Weekend Update:

For the new members who just joined us, welcome! For our loyal ones, a big Congrats on my recent picks!! My Multi-Bagger NSRS had another Blockbuster day on Friday just like I anticipated! Remember, on December 28th I announced NSRS at $0.29 as My New Big Pick and it has since Exploded, hitting an intra-day high of $0.63 Friday representing gains of 117% since I gave you this pick! My NEW Breakout Play NYXO had a Blockbuster day just like I anticipated! NYXO absolutely explode out of the gates Thursday, skyrocketing to an intra-day high of $0.30 representing 17% gains on a whopping 2.5 Million shares traded, that`s roughly 6X the 10d average volume traded! NYXO provided numerous intra-day gain opportunities throughout Thursday`s trading session… trading of its low of $0.24 NYXO then started gaining tremendous momentum hitting an intra-day high of $0.30 representing gains of 25% off its low of the day! I want to thank all of you that have been emailing me, and thanking me for all the great picks! We have had an overwhelming amount of new members in the last few weeks. We want to thank those of you that have referred your friends and co-workers to our newsletter.

For some of those new members that just joined check out the amazing performance of some of our recent picks.

Ticker: NYXO Name: Nyxio Tech Corp.

Website: www.nyxio.com Alert Price: $0.25 Alert Date: 1-11-2012 52-Wk Range: $0.0825 to $2.475 High Since Alert: $0.30 (GAIN OF 17%) Ticker: GNOM Name: Complete Genomics, Inc.

Website: www.completegenomics.com Alert Price: $2.95 Alert Date: 1-4-2012 52-Week Range: $2.57 to $18.55 High Since Alert: $3.89 (GAIN OF 31%) Ticker: NSRS Name: North Springs Resources Corp.

Website: www.northspringsresources.com Alert Price: $0.29 Alert Date: 12-28-2011 52-Week Range: $0.0075 to $0.63 High Since Alert: $0.63 (GAIN OF 117%) Ticker: CSOC Name: Caduceus Software Systems Corp.

Website: www.caduceusco.com Alert Price: $0.035 Alert Date: 12-19-2011 52-Week Range: $0.0186 to $0.20 High Since Alert: $0.039 (GAIN OF 11%) Ticker: VELA Name: VelaTel Global Communications Website: www.velatel.com Alert Price: $0.093 Alert Date: 12-14-2011 52-Week Range: $0.046 to $0.236 High Since Alert: $0. (GAIN OF 10%) Ticker: WLOL Name: Winland Ocean Shipping Corp.

Website: www.winlandshipping.com/ir Alert Price: $0.23 Alert Date: 12-5-2011 52-Week Range: $0.10 to $1.80 High Since Alert: $0.585 (GAIN OF 154%) Ticker: BVSN Name: BroadVision, Inc.

Website: www.BroadVision.com Alert Price: $8.65 Alert Date: 11-28-2011 52-Week Range: $7.82 to $18.4092 High Since Alert: $18.4092 (GAIN OF 112%) Ticker: AMWI Name: Amwest Imaging Incorporated Website: www.amwestimaging.com Alert Price: $0.18 Alert Date: 11-20-2011 I 52-Wk Range: $0.05 to $1.39 High Since Alert: $1.38 (GAIN OF 672%) NYXO + 17% GNOM + 31% NSRS + 117% CSOC + 11% VELA + 10% WLOL + 154% BVSN + 112% AMWI + 672%… Total Gains of 1124% As you can see our success if unbelievable… This clearly makes us the world`s best penny stock website! Very few newsletters have been on a WINNING STREAK like us , we have had Back to Back Winners! You Can`t Afford To Miss Our Picks! How would you like to grab hold of another Potential MONSTER pick like NYXO or NSRS Get ready, because I am researching a few different companies and will be announcing a new Big Pick shortly. Stay Tuned…

Sincerely, The OTCtipReporter TeamGENERAL NOTICE AND DISCLAIMER – PLEASE READ CAREFULLY The companies that are discussed on OTCtipReporter.com have not approved the statements made. This opinion contains forward-looking statements that involve risks and uncertainties. A company`s actual results could differ materially from those described in any forward-looking statements or announcements discussed herein. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCtipReporter.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Nor are any of its officers, affiliates, or employees. Please consult a broker before purchasing or selling any securities viewed on OTCtipReporter.com or mentioned herein.

Affiliates, officers, directors and employees of OTCtipReporter.com may have also bought or may buy shares of companies mentioned herein and may profit in the event those shares rise in value.

OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make their own decision based on his or her judgment of the market. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. We recommend you use the information found in this advertisement as an initial starting point for conducting your own research on the advertised company in order to determine your own personal opinion of the company before investing. All statements and opinions contained in this advertisement are the sole opinion of the authors and are subject to change without notice. We are not liable for any investment decisions by our readers. Readers should independently investigate and fully understand all risks before investing. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser or broker prior to completing any such purchase or sale decision. We are not registered investment advisers, or broker-dealers, or members of any financial regulatory bodies. Furthermore, our associates and/or employees and/or principals may have stock positions in advertised companies purchased in the open market or in private transactions. These positions may be liquidated, without prior notification, even after we have made positive comments regarding the advertised company. The receipt of this information constitutes your acceptance of these terms and conditions. Reading this advertisement shall not create under any circumstances an offer to buy or sell stock in any company advertised. Nor shall it create any principal-agent relationship between the reader and us. Void where prohibited. Information within this advertisement contains “forward looking” statements within the meaning of Section-27(a) of the U.S.

Securities Act-of-1933 and Section 21(e) of the U.S. Securities Exchange Act-of -934. Neither OTCtipReporter.com, its officers, affiliates, or employees is a broker-dealer. The information on OTCtipReporter.com, including the opinions expressed and the statements made within, is for informational and advertising purposes only and should not be construed as investment-advice, and does not constitute an offer to sell any securities, nor is it to be construed as a solicitation to purchase any securities in any state or other jurisdiction where the offer or sale is not permitted. The information to prepare this report is believed to be from reliable sources, but no representation is made as to the accuracy or completeness of such information. Investment in securities carries a high degree of risk and involves risks and uncertainties, which may result in investors losing all of their invested capital. Past performance does not guarantee future results.The information contained herein contains “forward-looking statements,” within the meaning of Section-27A of the Securities Act-of-1933 and Section 21E of the Securities Exchange Act-of-1934.

Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense competition, lack of meaningful research results, inadequate capital, termination of contracts or agreements, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in the reports filed with the Securities and Exchange Commission by the companies who are mentioned in this periodical. Readers should consult with their own professional investment, tax and portfolio advisors before making any investment decision and should independently verify all information herein.

More complete information about any of the companies mentioned in this periodical is available from the website of the Securities and Exchange Commission, at sec.gov, and copies of their filings may be read without charge and copies obtained at prescribed rates from the public reference facilities of the Commission, at 450 Fifth Street, NW, Washington, DC 20549.

Buying and Selling of Shares OTCtipReporter.com intends to sell its shares. OTCtipReporter.com may sell its shares for less than target prices given in opinions.

OTCtipReporter.com affiliates, officers, directors and employees may have also bought or may buy the shares discussed in this report and may profit in the event those shares rise in value.

OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. There are risks involved Always remember that OTCtipReporter.com are not analysts and investing in securities such as the ones listed within are for high risk tolerant individuals only and not the general public. Whether you are an experienced investor or not you should always consult with a broker before purchasing or selling any securities viewed on OTCtipReporter.com. If at any time you wish to be removed from our list simply

AMWI · BVSN · CSOC · GNOM · NSRS · NYXO · VELA · WLOL

According to Chip Maker Intel Smart TV Is The Device Of The Future! Read Why My NEW Breakout Play Could Be A Takeover Target Dear Fellow Investors, Coming off our recent two picks that saw gains of over 100% we felt there was no time like the present to keep the momentum rolling.

On the heels of those two major successes` we wanted to be very selective on our next alert. We couldn`t be more excited to bring you our next “Breakout Play” on:

Nyxio Technologies Corporation (NYXO) Nyxio is fast becoming a leading-edge driver and developer of technology for the consumer electronics industry. Featuring the VioSphere flat screen TV with integrated PC, Nyxio is dedicated to bringing revolutionary designs to market including tablet PCs, All-in-One PCs, Smart TVs, and groundbreaking concepts like the Venture “Mobile Media Viewer” (“VMMV”). The Company`s development process identifies technological deficiencies within the consumer electronics market and aims to develop product offerings that provide creative solutions aimed at improving operating efficiencies and to reduce the overall environmental footprint of end users.

As this super-Smart, touch-screen VioSphere gains exposure, it`s going to be the hottest thing out there, the new technology that 200 million American households will have to have.

It`s estimated that the U.S. market for Smart TVs will grow to whopping $500 billion by 2015! That`s why I`m anticipating this 23-cent stock to breakout (in the short term) and if Apple, Google or Samsung steps up to the plate GAME OVER!! If NYXO doesn`t get snapped up soon, long term, the sky is the limit. Buying shares of NYXO now could eventually be as profitable as getting in early on Apple. Read on and you`ll discover complete details about both the amazing do-everything, touch-screen TV that`s also a full-fledged PC, as well as Nyxio Technologies, the cutting edge company that makes this one-of-a-kind product.

In The Blink of An Eye… Every TV In the World Is Now Obsolete! You`ve got to admit, it`s been absolutely amazing… the way one disruptive technology after another has created a brand new market that`s put tens of millions, even billions into the pockets of investors who were early to act. First was the revolutionary iPod…

followed by the Smartphone… and then tablet PC`s. The NEXT, got-to-have-it advance in the technology sector is the revolutionary Smart TV, and as you are about to learn in this report, the market is HUGE and gaining tremendous momentum.

If you missed profits from Smartphones, Tablet PC`s, iPods or any of the multi-billion dollar technologies of the last decade, DON`T miss out on potential triple digit returns in the newest Tech Frontier! If you`re not yet aware WHY the Smart TV is about to change everything, I hope you`ll pay attention. You`re about to discover that this market is on the verge of explosive sales and why Nyxio Technologies (NYXO) is in line to rake in the lion`s share of those gigantic profits.

With a host of revolutionary products, Nyxio Technologies (NYXO) has launched their flagship product, The VioSphere Smart TV. With a potential market of $500 billion worldwide (for this ONE product), the potential profits are mind boggling.

The Worlds First and Only Fully Integrated Touch Screen TV and PC.

According to a report from Nielsen, the TV ratings company, 94% of consumers who were surveyed for a study on Internet TV said that they would prefer to be able to access digital content or surf the web on their TVs.

In a nut shell: NYXO is light years ahead of the competition with the development of the ONLY Smart TV that gives hundreds of millions of savvy consumers the features they want most. Everything needed to consume all the internet has to offer, coupled with brilliant HD TV, all from the comfort of your couch. There is nothing quite like it on the market…

And That Makes Nyxio a Prime Takeover Target by Apple, Google, Samsung or LG.

Research confirms Smart TV is the next logical progression after the smartphone.

What is a Smart TV Smart TV will blow your mind! It`s what entertainment lovers have always wanted but never had before. It integrates TV with the Internet, so everything important to the consumer is connected and searchable on a single, big HD flat screen.

Now you can have instant access to billions of hours of video or a wide selection of available apps and websites. Smart TV is interactive, complementing broadcast programming with the ability to instantly find and watch television shows and movies, download Internet applications, and easily surf between channels and Web sites for a completely new way of using television, instead of just watching it.

The Smart TV experience lets you search regular broadcast programming as well as online and personal content all from the same TV interface. It allows users to access downloadable applications, connect to social networks and access an infinite amount of entertainment possibilities.

With a Smart TV you can play movies, display photos, listen to music, and even update Social Networks right from your couch.

Netflix`s streaming service is booming. Hulu has a library with entire seasons of current TV shows. And anyone can create their own entertainment thanks to sites like YouTube and Vimeo.

As a result of Consumer Demand, the Smart TV is already upon us, in its various forms from various manufacturers. It has arrived with 3D capabilities, web browsing and social networking and applications. Currently Samsung and LG are the big players pushing the Smart TV to consumers. The demand is there, but there are obvious reasons why this market seems to have been waiting for what Nyxio Technologies (NYXO) has introduced…

Here`s Why Every Savvy Investor Should Pay Close Attention:

Because the TV/PC integration revolution is just around the corner from the Smartphone explosion and it could be even bigger. Century Capital Markets, in a letter released on Market-Wire in August, wrote that “The Smart TV market, still in its infancy, appears to have plenty of room to grow”. The release also goes on to cite that according to SNL Kagen, nearly 100 million Americans currently subscribe to some form of pay television, but only 4 million Smart TV`s were shipped in the US last year. The prediction is that the barn doors have been left open for innovators and manufacturers who are quick and brilliant to capture a strong and sudden foothold in the market.

And with its introduction of the world`s first and only combination TV/PC, Nyxio has established itself as the industry leader! Put Nyxio Technologies (NYXO) immediately on your watch list.

I have Nyxio Technologies (NYXO) as an immediate watch for its technological convergence genius, as demonstrated in its Smart TV and Tablet PCs. But you also need to check out its management.

If you missed the big moves on our recent two picks, YOU better Get Busy NOW and research NYXO and have it pulled up early Thursday morning! As always we encourage subscribers to do their own due diligence and visit the company website: www.nyxio.com Sincerely, The OTC tip Reporter Team P.S. Keep watching for my alerts, get ready for a Blockbuster day with our BRAND NEW ALERT NYXO!! Stay Tuned…

GENERAL NOTICE AND DISCLAIMER – PLEASE READ CAREFULLY The companies that are discussed on OTCtipReporter.com have not approved the statements made. This opinion contains forward-looking statements that involve risks and uncertainties. A company`s actual results could differ materially from those described in any forward-looking statements or announcements discussed herein. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCtipReporter.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Nor are any of its officers, affiliates, or employees. Please consult a broker before purchasing or selling any securities viewed on OTCtipReporter.com or mentioned herein.

Affiliates, officers, directors and employees of OTCtipReporter.com may have also bought or may buy shares of companies mentioned herein and may profit in the event those shares rise in value.

OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make their own decision based on his or her judgment of the market. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. We recommend you use the information found in this advertisement as an initial starting point for conducting your own research on the advertised company in order to determine your own personal opinion of the company before investing. All statements and opinions contained in this advertisement are the sole opinion of the authors and are subject to change without notice. We are not liable for any investment decisions by our readers. Readers should independently investigate and fully understand all risks before investing. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser or broker prior to completing any such purchase or sale decision. We are not registered investment advisers, or broker-dealers, or members of any financial regulatory bodies. Furthermore, our associates and/or employees and/or principals may have stock positions in advertised companies purchased in the open market or in private transactions. These positions may be liquidated, without prior notification, even after we have made positive comments regarding the advertised company. The receipt of this information constitutes your acceptance of these terms and conditions. Reading this advertisement shall not create under any circumstances an offer to buy or sell stock in any company advertised. Nor shall it create any principal-agent relationship between the reader and us. Void where prohibited. Information within this advertisement contains “forward looking” statements within the meaning of Section-27(a) of the U.S.

Securities Act-of-1933 and Section 21(e) of the U.S. Securities Exchange Act-of -934. Neither OTCtipReporter.com, its officers, affiliates, or employees is a broker-dealer. The information on OTCtipReporter.com, including the opinions expressed and the statements made within, is for informational and advertising purposes only and should not be construed as investment-advice, and does not constitute an offer to sell any securities, nor is it to be construed as a solicitation to purchase any securities in any state or other jurisdiction where the offer or sale is not permitted. The information to prepare this report is believed to be from reliable sources, but no representation is made as to the accuracy or completeness of such information. Investment in securities carries a high degree of risk and involves risks and uncertainties, which may result in investors losing all of their invested capital. Past performance does not guarantee future results.The information contained herein contains “forward-looking statements,” within the meaning of Section-27A of the Securities Act-of-1933 and Section 21E of the Securities Exchange Act-of-1934.

Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense competition, lack of meaningful research results, inadequate capital, termination of contracts or agreements, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in the reports filed with the Securities and Exchange Commission by the companies who are mentioned in this periodical. Readers should consult with their own professional investment, tax and portfolio advisors before making any investment decision and should independently verify all information herein.

More complete information about any of the companies mentioned in this periodical is available from the website of the Securities and Exchange Commission, at sec.gov, and copies of their filings may be read without charge and copies obtained at prescribed rates from the public reference facilities of the Commission, at 450 Fifth Street, NW, Washington, DC 20549.

Buying and Selling of Shares OTCtipReporter.com intends to sell its shares. OTCtipReporter.com may sell its shares for less than target prices given in opinions.

OTCtipReporter.com affiliates, officers, directors and employees may have also bought or may buy the shares discussed in this report and may profit in the event those shares rise in value.

OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. There are risks involved Always remember that OTCtipReporter.com are not analysts and investing in securities such as the ones listed within are for high risk tolerant individuals only and not the general public. Whether you are an experienced investor or not you should always consult with a broker before purchasing or selling any securities viewed on OTCtipReporter.com. If at any time you wish to be removed from our list simply

NYXO · VMMV